An integrated surgical smoke filtration and detoxification system. The system includes a housing that may include an interior chamber for detoxification and filtration performed by a detoxification system. The detoxification system may include a suction device and a filter and may be used to receive surgical smoke through a first portion of the chamber and exhaust detoxified surgical smoke through a second portion of the chamber.

An apparatus for microdisruption of cataracts in lens tissue by impulsive heat deposition comprising: a source of pulsed laser radiation, a user input device, a control circuit, and an optical waveguide configured to transmit the pulsed laser radiation. The light intensity which exits the optical waveguide has a wavelength selected to match an absorption peak of at least one component of the lens tissue, a pulse duration time shorter than a time required for thermal diffusion out of the laser irradiation volume and shorter than a time required for a thermally driven expansion of the laser irradiated volume, and a pulse energy resulting in a peak intensity of each laser pulse below a threshold for ionization-driven ablation to occur.

An apparatus for microdisruption of cataracts in lens tissue by impulsive heat deposition comprising: a source of pulsed laser radiation, a user input device, a control circuit, and an optical waveguide configured to transmit the pulsed laser radiation. The light intensity which exits the optical waveguide has a wavelength selected to match an absorption peak of at least one component of the lens tissue, a pulse duration time shorter than a time required for thermal diffusion out of the laser irradiation volume and shorter than a time required for a thermally driven expansion of the laser irradiated volume, and a pulse energy resulting in a peak intensity of each laser pulse below a threshold for ionization-driven ablation to occur.

An articulating instrument including a distal assembly having first and second configurations and intermediate configurations between them. At least one of the first and second configurations is substantially stable such that the distal assembly of the instrument has a tendency to remain in the stable configuration when placed in that configuration by a user of the instrument. Preferably, the distal assembly terminates in a distal tip unit defining at least one distal feature that is useful for manipulating tissue.

An articulating instrument including a distal assembly having first and second configurations and intermediate configurations between them. At least one of the first and second configurations is substantially stable such that the distal assembly of the instrument has a tendency to remain in the stable configuration when placed in that configuration by a user of the instrument. Preferably, the distal assembly terminates in a distal tip unit defining at least one distal feature that is useful for manipulating tissue.

The invention relates to a skin treatment device (10) for fractional treatment of the skin (100) of a human being. A radiation source (5) emits a multi-mode laser beam (20) with a superposition (23) of mutually different higher-order laser modes. The multi-mode laser beam is configured by said superposition of different laser modes to simultaneously cause a first plurality of high-intensity zones, where the thermal threshold (TC) for collagen denaturation for the treatment zone (50) of the skin is at least reached, and a second plurality of low-intensity zones where the thermal threshold (TF) for fibroblast stimulation for the treatment zone of the skin is at least reached. This is advantageous for obtaining a skin treatment device with a simple and therefore low-cost fractional laser skin treatment system for combined collagen denaturation and fibroblast stimulation. The skin treatment device is based on non-uniform laser radiation in the form of the multi-mode laser beam.

A medical apparatus includes a treatment device configured to be capable of treating a subject by applying energy to the subject, an optical fiber including a light emitting face for emitting light into the subject, the optical fiber being connected to the treatment device, and a shield portion that is disposed in front of the light emitting face of the optical fiber, the shield portion being configured to expose the light emitting face when the treatment device does not perform a treatment operation and to shield the light emitting face when the treatment device performs the treatment operation.

A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed tissue to place the radioactive substance in proximity to the capsule and remaining tissue, to spare the capsule and proximate nerves and vessels to treat tissue in proximity to the capsule. The elongate tubular member may comprise a channel such as a lumen to pass a bodily fluid such as urine when the expandable support engages the tissue to treat the patient for a plurality of days. The treatment apparatus can be used to resect and diagnose tissue concurrently. Based on the diagnosis, targeted segmental treatment may be given.

A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as to raise the target tissue or bodily target fluid temperature up to a predetermined temperature for a short period of time to achieve a therapeutic or prophylactic effect, while the average temperature rise of the target tissue or target fluid over a longer period of time is maintained at or below a predetermined level so as not to permanently damage the target tissue or target fluid.

Devices and methods for treating rhinitis are provided. An integrated therapy and imaging device is provided for single handheld use. The device may have a hollow elongated cannula, a therapeutic element coupled to a distal portion of the cannula, an imaging assembly coupled to the cannula to provide visualization of the therapeutic element, and an articulating region operably coupled to the imaging assembly to articulate the imaging assembly. The imaging assembly may be articulated so as to translate vertically, laterally, axially, and/or rotationally.